Trend
DailyNeutral
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Key levels
Resistance$0.29
Resistance$0.20
Latest news & SEC filings
ProductNew perimeter protection offering released by Tessera Defense and Homeland Security
DealTessera subsidiary Zorronet widens ties with D4P Group
DealTessera Defense unit Zorronet widens D4P Group collaboration into EU security and infrastructure
All HLSQ news →Tessera Defense & Homeland Security Inc. is a clinical-stage biotechnology company developing phage-based therapies that target harmful bacteria linked to chronic diseases. Its main programs include BX011, a fixed phage cocktail for diabetic foot infections, and BX211, a personalized phage treatment for diabetic foot osteomyelitis. The company also supports an NIH-led study of phage therapy in cystic fibrosis patients. It operates primarily in the United States and Israel.
Based on the company's 10-K filed Feb 19, 2026.
·
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HLSQ.
Start Free Trial →Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
5
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for HLSQ, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:07:13 | $0.07 | 30,000 | $$2K | BUY |
| 15:07:07 | $0.07 | 2,000 | $$139 | SELL |
| 15:06:58 | $0.07 | 1,000 | $$70 | SELL |
| 15:05:51 | $0.07 | 7,700 | $$531 | SELL |
| 15:05:35 | $0.07 | 1,000 | $$72 | BUY |
5 dark pool trades shown · $$3K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for HLSQ (HLSQ) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HLSQ (HLSQ) is at $0.07, down 37.43% (-$0.04) at the Nov 10, 2026 close.
Latest HLSQ news — Nov 11, 2026: New perimeter protection offering released by Tessera Defense and Homeland Security · Nov 11, 2026: Tessera subsidiary Zorronet widens ties with D4P Group
HLSQ last reported on Nov 12, 2025: EPS -$55.10 vs -$56.05 expected — a beat of 1.7%.
Resistance: $0.20, $0.29, $1.49.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 11, 2026: New perimeter protection offering released by Tessera Defense and Homeland Security · Nov 11, 2026: Tessera subsidiary Zorronet widens ties with D4P Group · Nov 9, 2026: Tessera Defense unit Zorronet widens D4P Group collaboration into EU security and infrastructure